InSitu Biologics is developing a multi-phase, localized drug delivery platform for the extended release of therapeutics targeting pain, cancer, and infection. Their technology aims to provide precise elution rates for drug administration, addressing the need for effective peri-operative pain management and localized cancer treatment.
Funding
$5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Post-operative pain management often relies on systemic drugs, leading to potential side effects and incomplete pain relief. Localized cancer treatments can lack precision, affecting healthy tissue surrounding the tumor. Current drug delivery methods may not provide consistent and prolonged therapeutic release.
Solution
InSitu Biologics is developing a multi-phase drug delivery platform for localized, extended-release of therapeutics targeting pain, cancer, and infection. Their technology allows for precise control over drug elution rates, enabling targeted drug administration directly at the site of action. The platform aims to improve post-operative pain management by providing extended local analgesia, reducing the need for systemic opioids. For cancer treatment, the platform delivers chemotherapy drugs directly to the tumor site, minimizing off-target effects. The multi-phase release mechanism ensures consistent drug concentrations over a pre-programmed duration, optimizing therapeutic efficacy.
Target Audience
The primary target audience includes surgeons, oncologists, and pain management specialists seeking improved localized drug delivery solutions for post-operative pain and cancer treatment.
Features
- INSB200™: Extended-release pain control solution for peri-operative pain management.
- INSB400™: Early-development product focused on local delivery of cancer drugs with a precise elution rate over a pre-programmed period.
- Multi-phase release mechanism for consistent drug concentrations.
- Localized drug delivery to minimize systemic side effects.
- Customizable elution rates for tailored therapeutic profiles.